Mikhail V. Chernov

2.8k citations

15 papers · 2.3k indexed · 1 hit paper · h-index 13

Co-authors: Andrei V. Gudkov Roman V. Kondratov Elena A. Komarova Pavel G. Komarov John S. Coon Peter M. Chumakov Valeria Ossovskaya Marina P. Antoch
Topics: Cancer-related Molecular Pathways (8 papers)Ubiquitin and proteasome pathways (3 papers)Circadian rhythm and melatonin (3 papers)
Cited by: Aging Endocrine and Autonomic Systems Oncology
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United States Russia Canada

In The Last Decade

Mikhail V. Chernov

15 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy

1999 1.1k citations Pavel G. Komarov, Elena A. Komarova et al. Science profile →

Peers

Countries citing papers authored by Mikhail V. Chernov

Since Specialization

Citations

This map shows the geographic impact of Mikhail V. Chernov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail V. Chernov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail V. Chernov more than expected).

Fields of papers citing papers by Mikhail V. Chernov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail V. Chernov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail V. Chernov. The network helps show where Mikhail V. Chernov may publish in the future.

Co-authorship network of co-authors of Mikhail V. Chernov

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail V. Chernov. A scholar is included among the top collaborators of Mikhail V. Chernov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail V. Chernov. Mikhail V. Chernov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Development of a High-Throughput Biochemical Assay to Screen for Inhibitors of Aerobactin Synthetase IucA 2018 ·SLAS DISCOVERY ·(unknown),(unknown),Mikhail V. Chernov,Andrew M. Gulick	5
2	Targeting RING domains of Mdm2–MdmX E3 complex activates apoptotic arm of the p53 pathway in leukemia/lymphoma cells 2015 ·Cell Death and Disease ·Wenjie Wu,Chao Xu,(unknown),Chuandong Fan,(unknown),Mikhail V. Chernov,Leigh Ellis,(unknown),Inés G. Muñoz,(unknown)	33
3	Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1 2011 ·Oncotarget ·(unknown),Mary L. Spengler,Karen K. Kuropatwinski,Maria Comas,Marilyn Jackson,Mikhail V. Chernov,Anatoli S. Gleiberman,Natalia Fedtsova,Youcef M. Rustum,Andrei V. Gudkov,Marina P. Antoch	30
4	Pharmacological modulators of the circadian clock as potential therapeutic drugs 2009 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Marina P. Antoch,Mikhail V. Chernov	15
5	Posttranslational Regulation of Circadian Transcriptional Clock (NPAS2)/BMAL1 Complex by Cryptochromes 2006 ·Cell Cycle ·Roman V. Kondratov,Anna A. Kondratova,Choogon Lee,Victoria Gorbacheva,Mikhail V. Chernov,Marina P. Antoch	63
6	p53 is a suppressor of inflammatory response in mice 2005 ·The FASEB Journal ·Elena A. Komarova,Vadim I. Krivokrysenko,Kaihua Wang,Nickolay Neznanov,Mikhail V. Chernov,Pavel G. Komarov,Marie‐Luise Brennan,(unknown),Oskar W. Rokhlin,Dmitry V. Kuprash,Sergei A. Nedospasov,(unknown),Elena Feinstein,Andrei V. Gudkov	205
7	Selection–subtraction approach (SSA): A universal genetic screening technique that enables negative selection 2004 ·Proceedings of the National Academy of Sciences ·Aatur D. Singhi,Roman V. Kondratov,Nickolay Neznanov,Mikhail V. Chernov,Andrei V. Gudkov	6
8	BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system 2003 ·Genes & Development ·Roman V. Kondratov,Mikhail V. Chernov,Anna A. Kondratova,Victoria Gorbacheva,Andrei V. Gudkov,Marina P. Antoch	203
9	p53 Inhibitor Pifithrin α Can Suppress Heat Shock and Glucocorticoid Signaling Pathways 2003 ·Journal of Biological Chemistry ·Elena A. Komarova,Nickolay Neznanov,Pavel G. Komarov,Mikhail V. Chernov,Kaihua Wang,Andrei V. Gudkov	96
10	Regulation of Ubiquitination and Degradation of p53 in Unstressed Cells through C-terminal Phosphorylation 2001 ·Journal of Biological Chemistry ·Mikhail V. Chernov,Lora Jh Bean,Natalia Lerner,George R. Stark	48
11	A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapybreakdown → 1999 ·Science ·Pavel G. Komarov,Elena A. Komarova,Roman V. Kondratov,(unknown),John S. Coon,Mikhail V. Chernov,Andrei V. Gudkov	1079
12	The candidate tumour suppressor p33ING1cooperates with p53 in cell growth control 1998 ·Nature ·Igor Garkavtsev,Irina A. Grigorian,Valeria Ossovskaya,Mikhail V. Chernov,Peter M. Chumakov,Andrei V. Gudkov	244
13	Stabilization and activation of p53 are regulated independently by different phosphorylation events 1998 ·Proceedings of the National Academy of Sciences ·Mikhail V. Chernov,Chilakamarti V. Ramana,Victor Adler,George R. Stark	70
14	Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains. 1996 ·Proceedings of the National Academy of Sciences ·Valeria Ossovskaya,Ilya Mazo,Mikhail V. Chernov,Olga Chernova,Žaklina Strezoska,Roman V. Kondratov,George R. Stark,Peter M. Chumakov,Andrei V. Gudkov	157
15	p53-dependent growth arrest of REF52 cells containing newly amplified DNA. 1995 ·Proceedings of the National Academy of Sciences ·Yukihito Ishizaka,Mikhail V. Chernov,Christopher M. Burns,George R. Stark	33

About Mikhail V. Chernov

Mikhail V. Chernov is a scholar working on Aging, Endocrine and Autonomic Systems and Oncology, having authored 15 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Ubiquitin and proteasome pathways (3 papers) and Circadian rhythm and melatonin (3 papers). The work is most often cited by research in Aging (99 citations), Endocrine and Autonomic Systems (285 citations) and Oncology (945 citations). Mikhail V. Chernov has collaborated with scholars based in United States, Russia and Canada. Frequent co-authors include Andrei V. Gudkov, Roman V. Kondratov, Elena A. Komarova, Pavel G. Komarov, John S. Coon, Peter M. Chumakov, Valeria Ossovskaya, Marina P. Antoch, George R. Stark and Victoria Gorbacheva. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact